Jul 19, 2019 / 01:30PM GMT
Operator
Good day, and welcome to the Sartorius and Sartorius Stedim Biotech Conference Call on the Half Year 2019 Results. Today's conference is being recorded. At this time, I would like to turn the conference over to Dr. Joachim Kreuzburg, CEO. Please go ahead, sir.
Joachim Kreuzburg - Sartorius Stedim Biotech S.A. - Chairman & CEO
Welcome to the Conference Call for Half Year's Result for 2019 for Sartorius and Sartorius Stedim Biotech. As always, together with our CFO, Rainer Lehmann, I would like to walk you through the figures for the Sartorius Group, and then directly thereafter we will also present the Sartorius Stedim Biotech's figures to you, and then we have time for Q&A.
Let me kick that off with talking about the key highlights for the first half of 2019. Again, we have been able to achieve double-digit growth for sales revenue and order intake and also profits -- actually, above average increase of the profit and therefore an expansion of our profit margin. You would see that in a minute in more detail. The Bioprocess Solutions division
Half Year 2019 Sartorius AG Earnings Call Transcript
Feb 14, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers